APA (7th ed.) Citation

National Research Tomsk Polytechnic University, Liu Yongsheng, Xu Tianqi, Vorobjeva A. G. Anzhelika Grigorjevna, Loftenius Annika, Bodenko V. V. Vitalina Vasiljevna, . . . Tolmachev V. M. Vladimir Maksimilianovich. (2023). Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab. 2023. https://doi.org/10.3390/cancers15092409

Chicago Style (17th ed.) Citation

National Research Tomsk Polytechnic University, Liu Yongsheng, Xu Tianqi, Vorobjeva A. G. Anzhelika Grigorjevna, Loftenius Annika, Bodenko V. V. Vitalina Vasiljevna, Orlova A. M. Anna Markovna, Frejd Y. F. Fredrik, and Tolmachev V. M. Vladimir Maksimilianovich. Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab. 2023, 2023. https://doi.org/10.3390/cancers15092409.

MLA (9th ed.) Citation

National Research Tomsk Polytechnic University, et al. Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab. 2023, 2023. https://doi.org/10.3390/cancers15092409.